Efficacy and Safety of Lisdexamfetamine Dimesylate in Children with Attention-Deficit/Hyperactivity Disorder and Recent Methylphenidate Use

INTRODUCTION: Lisdexamfetamine dimesylate (LDX) is a long-acting prodrug stimulant for the treatment of attention-deficit/hyperactivity disorder (ADHD). Post hoc subgroup analyses were performed from two studies in children with ADHD to compare the efficacy of LDX in participants who had received pr...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Jain, Rakesh, Babcock, Thomas, Burtea, Teodor, Dirks, Bryan, Adeyi, Ben, Scheckner, Brian, Lasser, Robert, Renna, John, Duncan, Don
Format: Artigo
Jezik:Inglês
Izdano: Springer Healthcare 2013
Teme:
Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3680667/
https://ncbi.nlm.nih.gov/pubmed/23681505
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-013-0027-2
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki